<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='986-1662'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/profile/">Profile</a>
<span>Lung Cancer Mutation Panel 3- EGFR Sequencing with ALK-1 IHC & ROS-1 by FISH </span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">Lung Cancer Mutation Panel 3- EGFR Sequencing with ALK-1 IHC & ROS-1 by FISH </h1>
<div class="post-text">
<p>Lung cancer is a serious condition characterized by the uncontrolled growth of cells in the lungs. These cells can sometimes have mutations, or changes, in their DNA that allow them to grow and divide more rapidly. The Lung Cancer Mutation Panel 3 aims to identify some of these mutations. Specifically, it looks for changes in the EGFR gene by sequencing, ALK gene rearrangements by immunohistochemistry (IHC) using ALK-1 antibody, and ROS-1 gene rearrangements using Fluorescence in situ hybridization (FISH) technique.
 </p>
<p>EGFR, ALK, and ROS-1 are all genes that provide instructions for making proteins involved in cell growth and division. Mutations or changes in these genes can lead to an overactive protein, triggering the development of lung cancer. Identifying these mutations helps doctors understand more about each patient's unique form of cancer, potentially leading to more targeted and effective treatment strategies. </p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Profile Name</th>
			<td scope="col">Lung Cancer Mutation Panel 3- EGFR Sequencing with ALK-1 IHC & ROS-1 by FISH </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Tissue/Blood
 </td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>There are no specific instructions regarding fasting, water consumption or restrictions, or any other preparation for this test. 
 </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>2 days </td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>₹ 24000 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
	<h2 class="test-h2 mt-3">What is EGFR sequencing? </h2>
	<p>EGFR sequencing is a laboratory method used to read the genetic code of the EGFR gene in cancer cells. This method can identify mutations in the EGFR gene, which can be targeted by specific treatments.
 </p>
	<h2 class="test-h2 mt-3">What is ALK-1 IHC? 
 </h2>
	<p>ALK-1 IHC is a technique used to identify ALK gene rearrangements in cancer cells. An ALK-1 antibody is used to bind to the ALK protein in cells where the gene is rearranged and overactive. </p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
	<h2 class="test-h2 mt-3">What is ROS-1 FISH? </h2>
<p>ROS-1 FISH is a laboratory method used to identify rearrangements in the ROS-1 gene in cancer cells. This technique uses fluorescent probes that bind to the ROS-1 gene if it is rearranged.</p>

	<h2 class="test-h2 mt-3">What does it mean if I have a mutation in one of these genes? </h2>
<p>A mutation in one of these genes means that your cancer may be driven by this mutation. This could impact your treatment options, as certain targeted therapies are designed to target these specific genetic changes.</p>

	<h2 class="test-h2 mt-3">Can these mutations be inherited? </h2>
<p>Most mutations found in lung cancer are acquired during a person's lifetime and are not inherited. This means that these mutations are not typically passed down from parents to their children.</p>

	<h2 class="test-h2 mt-3">Can the results of this test affect my treatment options? </h2>
<p>Yes, the results of this test can significantly impact your treatment options. If a specific mutation is identified, targeted therapies can be used to specifically treat your type of cancer.</p>

	<h2 class="test-h2 mt-3">Can the results of this test change over time? </h2>
<p>Yes, the genetic makeup of a tumor can change over time, particularly in response to treatment. Your doctor may recommend repeat testing if your cancer progresses or if you become resistant to treatment.</p>

	<h2 class="test-h2 mt-3">How is the test performed? </h2>
<p>This test is performed on a sample of your blood or tissue. Your doctor will provide instructions on how and when the sample will be collected.</p>

	<h2 class="test-h2 mt-3">How long will it take to get the results? </h2>
<p>It typically takes about 7-10 days to receive the results of this test. However, the timing can vary depending on the lab.</p>

	<h2 class="test-h2 mt-3">Are there any risks associated with this test? </h2>
<p>There may be slight risks associated with the sample collection process. If a tissue sample is taken, you may experience minor discomfort, bleeding, or infection at the biopsy site.</p>

	<h2 class="test-h2 mt-3">What happens if my test results are positive? </h2>
<p>A positive result indicates the presence of a mutation in one or more of the tested genes. This information will be used by your healthcare provider to tailor your treatment plan.</p>

	<h2 class="test-h2 mt-3">Is this test covered by insurance?</h2>
<p>The coverage of this test depends on your health insurance policy. Please check with your insurance provider for specific details.</p>

	<h2 class="test-h2 mt-3">Are the test results conclusive?</h2>
<p> While the results of this test are usually accurate, no test is 100% definitive. You should discuss your results and their implications with your healthcare provider.</p>

	<h2 class="test-h2 mt-3">Can this test be used to track the progression of my disease?</h2> 
<p>This test is primarily used to identify targetable mutations in your cancer. Other tests may be more suitable for monitoring disease progression.</p>

	<h2 class="test-h2 mt-3">Can this test predict my response to treatment?</h2> 
	<p>Yes, this test can help predict your response to certain targeted therapies. However, other factors may also influence your response to treatment.</p>

	<h2 class="test-h2 mt-3">Can this test detect all types of lung cancer mutations? </h2>
<p>While this panel tests for mutations in the EGFR, ALK, and ROS-1 genes, it does not cover all possible mutations that can occur in lung cancer. There are many other mutations which may not be covered by this panel.</p>

	<h2 class="test-h2 mt-3">What happens if my test results are negative? </h2>
<p>A negative result means that the tested mutations were not detected in your sample. However, it does not rule out the presence of other mutations not covered by this test or that your cancer is not driven by a genetic mutation.</p>

	<h2 class="test-h2 mt-3">How often should I get this test done?</h2>
<p> The frequency of this test will depend on your individual circumstances. Your healthcare provider will give you specific guidance based on your condition and response to treatment.</p>

	<h2 class="test-h2 mt-3">Can this test be done at any laboratory? </h2>
<p>This test requires specific expertise and equipment, and may not be available at all labs. It is important to have this test performed at a specialized lab with experience in genetic testing for cancer.</p>

	<h2 class="test-h2 mt-3">Can lifestyle changes or medications influence the test results? </h2>
<p>Lifestyle changes or medications generally do not influence the results of this genetic test. However, it’s always important to inform your doctor about any medications you are taking or lifestyle changes you’ve made.</p>

	<h2 class="test-h2 mt-3">Can this test be used to determine if I am a carrier for lung cancer?</h2> 
<p>This test is not designed to determine carrier status as most mutations linked with lung cancer are not hereditary. They are acquired mutations, which occur during a person’s lifetime.</p>

	<h2 class="test-h2 mt-3">How reliable is this test in detecting lung cancer mutations? </h2>
<p>The Lung Cancer Mutation Panel 3 is generally very reliable in detecting the specific mutations it is designed to find. However, the sensitivity and specificity can depend on the type and quality of the sample used for the test.</p>

	<h2 class="test-h2 mt-3">What types of treatments are available if a mutation is detected? </h2>
<p>If a mutation is detected, targeted therapies designed to interfere with the function of the mutated proteins may be available. These therapies may be more effective and cause fewer side effects than traditional chemotherapy.</p>

	<h2 class="test-h2 mt-3">How does understanding the genetic makeup of my cancer benefit me? </h2>
<p>Understanding the genetic makeup of your cancer can help your doctor choose treatments that are more likely to be effective. It can also help identify clinical trials for which you may be eligible.</p>

	<h2 class="test-h2 mt-3">Will the test need to be repeated? </h2>
<p>Your doctor may recommend repeating the test if your cancer progresses, if there is a change in your condition, or if you develop resistance to a targeted therapy.</p>

</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>